Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27225344 | 1.00 | ACACB (0.39) | ACACBACACA | |
| SCHEMBL27224935 | 0.86 | ACACB (0.42) | ACACB | |
| SCHEMBL27231864 | 0.86 | ACACB (0.42) | ACACB | |
| SCHEMBL15641652 | 0.83 | ACACB (0.41) | ACACBACACA | |
| SCHEMBL15641653 | 0.83 | ACACB (0.41) | ACACBACACA | |
| SCHEMBL27225071 | 0.82 | CA1 (0.38) | ACACBACACA | |
| SCHEMBL27231862 | 0.82 | CA1 (0.38) | ACACBACACA | |
| SCHEMBL12327708 | 0.81 | MEN1 (0.31) | ACACBACACA | |
| SCHEMBL2549209 | 0.78 | ACACB (0.38) | ACACBACACA | |
| SCHEMBL15641656 | 0.74 | ACACB (0.36) | ACACBACACA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240173419-A1 | CDK2 DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS, INC. | 2024-05-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240173419-A1 | CDK2 DEGRADERS AND USES THEREOF | CDK2, CDK20, CDK1 | ACACB 2117/4885ACACA 2581/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.